$PRAN Recent News U.S. stocks rise; S&P 500, Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board

Dec 12, 2014 at 10:40 AM

$PRAN Recent News

U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains 3:47 p.m. March 31, 2014 - Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses 2:30 p.m. March 31, 2014 - Sue Chang
Biotech's shares fall 70% on tests 11:39 a.m. March 31, 2014 - Russ Britt
U.S. stock futures extend gains ahead of Yellen 7:58 a.m. March 31, 2014 - Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial 6:50 a.m. March 31, 2014 - Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails 6:22 a.m. March 31, 2014 - Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:11 p.m. Feb. 18, 2014 - Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results 3:24 p.m. Feb. 18, 2014 - Russ Britt
Prana's Huntington disease therapy meets endpoints 11:51 a.m. Feb. 18, 2014 - MarketWatch.com
Prana Biotechnology up 19% in premarket 8:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 1:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 2:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 10:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 12:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 3:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 10:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 9:20 a.m. March 22, 2011 - Val Brickates Kennedy

Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog 1:00 p.m. Oct. 7, 2014 - Zacks.com
Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog 4:35 p.m. Sept. 8, 2014 - Zacks.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 8:46 a.m. Sept. 5, 2014 - TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 1:05 p.m. July 17, 2014 - TheStreet.com
Prana shares up premarket on clinical trial update 8:22 a.m. July 17, 2014 - Seeking Alpha
Prana Biotechnology (PRAN) Stock Suddenly Surges 2:28 p.m. May 27, 2014 - TheStreet.com
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure 3:15 p.m. April 14, 2014 - Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble? 10:16 a.m. April 14, 2014 - Seeking Alpha
Prana collapses after trial fails 5:57 a.m. March 31, 2014 - Seeking Alpha
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors 2:49 p.m. March 20, 2014 - Seeking Alpha
Prana to join Aussie index for top 300 companies 9:00 a.m. March 11, 2014 - Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations 8:38 a.m. March 7, 2014 - Seeking Alpha
Prana Biotech Alzheimer approach supported by study 10:49 a.m. March 6, 2014 - Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? 3:24 p.m. March 4, 2014 - Seeking Alpha
Prana: Right Drug, Wrong Dose 9:38 a.m. March 3, 2014 - Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results 6:45 a.m. March 1, 2014 - Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor 10:12 a.m. Feb. 24, 2014 - Seeking Alpha
Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors 12:45 p.m. Feb. 22, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 20 7:30 a.m. Feb. 21, 2014 - Seeking Alpha

The Lancet Neurology Publishes Prana's Huntington Disease Trial 11:01 a.m. Nov. 19, 2014 - BusinessWire - BZX
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease 6:45 a.m. Sept. 5, 2014 - PR Newswire - PRF
Prana Alzheimer's disease Development Program update 3:10 p.m. July 17, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 6:04 a.m. July 14, 2014 - PR Newswire - PRF
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 4:10 a.m. July 14, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology 6:10 a.m. June 11, 2014 - PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics 10:29 a.m. May 19, 2014 - PR Newswire - PRF
World leader in movement disorders Professor Ira Shoulson joins Prana Board 6:30 a.m. May 14, 2014 - PR Newswire - PRF
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 10:34 a.m. April 23, 2014 - PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited 8:03 a.m. April 23, 2014 - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 9:47 a.m. April 16, 2014 - ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 8:49 a.m. April 2, 2014 - ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year 1:00 a.m. April 1, 2014 - ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease 6:05 a.m. March 31, 2014 - PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 11:19 a.m. March 28, 2014 - PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective 8:30 a.m. March 4, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 12:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease 6:02 a.m. Feb. 18, 2014 - PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 8:00 a.m. Dec. 20, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nucor's Q3 2026 Earnings: Strong Growth Amid Steel Surge

Nucor's Solid Third Quarter Performance Nucor Corporation is flexing its muscles, reporting a robust third quarter for 2026. With net earnings hitting $1.32 billion and a diluted earnings per share of $5.80, the steel giant has shown it can more than hold its ground in a competitive market. Compare that to last quarter's $1.16 billion - we're seeing serious momentum....

Pacsun Finds Gear: 177% Sales Surge at F1 Austin!

New Heights in Trackside Fashion Well, it looks like Pacsun's got a knack for making the Austin F1 scene as thrilling as the race itself, weaving fashion into the high-speed atmosphere. This year's Formula 1 United States Grand Prix in Austin brought a whopping 19% sales swell in 2026, marking a total sales increase of 177% since their initial 2023 Austin pop-up. Talk...

NACCO Industries Preps for Q3 Results and Call

Anticipation Builds for NACCO's Q3 Financial Insights From the streets of Cleveland, NACCO Industries is ramping up to release their third quarter financial results for 2026. Mark your calendars for November 4, just after the market packs up for the day. Now, isn't it something to watch how these earnings reports seem to become a spectacle all their own? Promising...

Bank of America Faces Legal Battle Over Compliance Failures

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...

Govee's Retro Holiday Lights: A Festive Nostalgia Trip

Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...

Unlocking AI Edge with Workplace Data and Human Insight

Insights from the SPS Report on AI and Workplace Data When data, AI, and human context play in harmony, businesses dance to a new tune. SPS has shed some light on this dynamic in their freshly minted report, "Turning Workplace Data into a Competitive Advantage." Now, anyone paying attention to the tech-driven evolution of business will see that merely piling up workplace...

Sands China's Latest Move: A Bond Offering Twist

Breaking Down Sands China's Bond Maneuver Today, we found out that Sands China is teeing up a fresh round of senior unsecured notes. Now, if that doesn't get your ticker flickin', maybe you're too used to market snoozefests. The folks at the helm of Sands China, a subsidiary under the mighty Las Vegas Sands Corp. (NYSE: LVS), are rolling out these USD-denominated notes...

Tempo's Protein Max Meals: A High-Protein Revolution

Packed Protein, Zero Hassle Every once in a while, something comes along in the food sector that changes the game. Tempo's Protein Max meals might just be it. Launching with a hefty 40 grams of protein in every serving, these meals promise a powerful punch for anyone who's serious about meeting their protein counts without spending hours in the kitchen. Two minutes flat...

Beer B Que Music Festival: Hip-Hop, Dancehall & Brews

A Melody and Brew-Infused South Florida Celebration Boy, if festivals were stocks, I'd have bought into the Beer B Que Music Festival years ago. This event, rolling into its seventh year, isn't just another line-up of artists—it feels like a genuine cultural reunion for folks in South Florida. You throw in some heavyweight names like Rick Ross and Kodak Black, plus the...

Worldline Crowned as 2026 SPARK Matrix Leader

Worldline's Journey to Leadership When you talk about the big dogs in payment services, Worldline’s name crops up for a reason. They've just snagged a top spot in the 2026 SPARK Matrix by the QKS Group, putting them in the limelight as a leader in Merchant Payment Platform technology. If you're in payments, this is worth a double take. The SPARK Matrix Breakdown The...